Pompe disease: a country-wide molecular screening in a cohort of 15; 068 study participantsFrontiers in Molecular BiosciencesIF42026-01-300OAAI
Analysis of LRRN3, MEF2C, SLC22A, and P2RY12 Gene Expression in the Peripheral Blood of Patients in the Early Stages of Parkinson's DiseaseBIOMEDICINESIF3.92024-06-230OAAI
Evaluation of the MRI contrast of locus coeruleus in patients with neurodegenerative diseasesJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22023-12-010PRE
Clinical features of Alzheimer's disease presenting as corticobasal syndromeJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22023-12-010PRE
Memory impairment in patients with behavioral variant of frontotemporal dementiaJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22023-12-010PRE
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort拥抱单基因帕金森病: MJFF全球遗传PD队列MOVEMENT DISORDERSIF7.62023-01-2424OAAI
Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy PersonalizationDIAGNOSTICSIF3.32020-05-2523OAAI
Blood Lysosphingolipids Accumulation in Patients With Parkinson's Disease With Glucocerebrosidase 1 MutationsMOVEMENT DISORDERSIF7.62018-09-0736PREAI
Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson's DiseaseFRONTIERS IN AGING NEUROSCIENCEIF4.52018-05-1516OAAI
New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)JOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22015-02-0119PREAI
Transcranial sonography in Parkinson's disease: diagnostic and prognostic applicationPARKINSONISM & RELATED DISORDERSIF3.42009-12-010PREAI